Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Psychiatr Serv. 2019 Oct 16:appips201900180. doi: 10.1176/appi.ps.201900180. [Epub ahead of print]

Neonatal Abstinence Syndrome and Childhood Mental Health Conditions, 2009-2015: Commercial Versus Medicaid Populations.

Author information

1
Department of Pharmacy Practice and Science, Institute for Pharmaceutical Outcomes & Policy, University of Kentucky College of Pharmacy (Conner, Delcher, Talbert), and Department of Psychiatry and Department of Pediatrics, University of Kentucky College of Medicine (Meadows), Lexington.

Abstract

OBJECTIVE:

This study aimed to examine mental health conditions of children diagnosed with neonatal abstinence syndrome (NAS) in a commercially insured population and compare them with a multistate Medicaid-insured population identified in prior research.

METHODS:

Data from the IBM MarketScan Commercial Database from January 1, 2009, to September 30, 2015, were used to identify mental health conditions among children ages 1-5 both with and without NAS. Frequency analyses were conducted to ascertain intrapopulation differences and differences between the commercially insured and Medicaid populations.

RESULTS:

The NAS rate in the Medicaid population was 28.7 times higher than in the commercially insured population. Although the sample of children with NAS was small, and the results must be interpreted with caution, elevated rates of childhood mental health conditions observed in the commercially insured population were comparable to the Medicaid population.

CONCLUSIONS:

This analysis emphasizes the difference in rates of NAS between commercially insured and Medicaid populations.

KEYWORDS:

Alcohol and drug abuse; Child psychiatry; Health insurance; Mental health; NAS; Neonatal abstinence syndrome

PMID:
31615364
DOI:
10.1176/appi.ps.201900180

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center